YIH
Y-Intercept (HK)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,720
| Closed | -$1M | – | 1610 |
|
2025
Q1 | $1M | Sell |
3,720
-796
| -18% | -$215K | 0.07% | 404 |
|
2024
Q4 | $1.06M | Buy |
+4,516
| New | +$1.06M | 0.07% | 403 |
|
2024
Q3 | – | Sell |
-46,388
| Closed | -$11.3M | – | 1269 |
|
2024
Q2 | $11.3M | Buy |
46,388
+43,545
| +1,532% | +$10.6M | 0.62% | 11 |
|
2024
Q1 | $425K | Buy |
2,843
+988
| +53% | +$148K | 0.03% | 796 |
|
2023
Q4 | $355K | Buy |
+1,855
| New | +$355K | 0.03% | 757 |
|
2022
Q4 | – | Sell |
-5,935
| Closed | -$1.19M | – | 972 |
|
2022
Q3 | $1.19M | Buy |
+5,935
| New | +$1.19M | 0.12% | 267 |
|
2022
Q1 | – | Sell |
-3,134
| Closed | -$531K | – | 706 |
|
2021
Q4 | $531K | Buy |
+3,134
| New | +$531K | 0.13% | 235 |
|
2021
Q3 | – | Sell |
-7,592
| Closed | -$1.29M | – | 629 |
|
2021
Q2 | $1.29M | Buy |
7,592
+3,832
| +102% | +$650K | 0.33% | 59 |
|
2021
Q1 | $508K | Buy |
+3,760
| New | +$508K | 0.14% | 254 |
|